MICHAEL POWELL

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Lara Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MICHAEL POWELL:

Company Role Class Num Shares Value Price $ Report Date Ownership
Galera Therapeutics, Inc. Director Stock Option (Right to Buy) 64,000 14 Jun 2023 Direct
Bicara Therapeutics Inc. Director Stock Option (Right to Buy) 23,746 09 Jun 2025 Direct
Checkmate Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 31 May 2022 Direct

Insider Reports Filed by MICHAEL POWELL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCAX Bicara Therapeutics Inc. 09 Jun 2025 1 $0 4 Director 10 Jun 2025, 16:30
BCAX Bicara Therapeutics Inc. 12 Sep 2024 0 $0 3 Director 12 Sep 2024, 21:16
GRTX Galera Therapeutics, Inc. 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:15
GRTX Galera Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 16:05
CMPI Checkmate Pharmaceuticals, Inc. 31 May 2022 3 $0 4 Director 31 May 2022, 10:14
CMPI Checkmate Pharmaceuticals, Inc. 09 Aug 2021 1 $0 4 Director 10 Aug 2021, 16:05
CMPI Checkmate Pharmaceuticals, Inc. 16 Jun 2021 1 $0 4 Director 21 Jun 2021, 21:18
GRTX Galera Therapeutics, Inc. 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 18:39